Da Hea Seo

Da Hea Seo

Auto-generated profile, based on publicly available information

Da Hea Seo

Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HPHye-Sun Park
Hye-Sun Park
YCYongin Cho
Yongin Cho
DSDa Hea Seo
Da Hea Seo
SASeong Hee Ahn
Seong Hee Ahn
SHSeongbin Hong
Seongbin Hong
SKSo Hun Kim
So Hun Kim
The effect of diabetes distress on glycemic control and its association with diabetes complications is still poorly understood. We aimed to study the clinical features of patients with high diabetes distress, focusing on changes in glycemic control and risk of diabetic complications. From the Korean National Diabetes Program data, we investigated 1862 individuals with type 2 diabetes mellitus (T2DM) who completed diabetic complication studies and the Korean version of the Problem Areas in Diabetes Survey (PAID-K). A total score of PAID-K ≥ 40 was considered indicative of high distress. Individuals with high distress (n = 589) had significantly higher levels of glycated hemoglobin than those without distress (7.4% vs. 7.1%, p < 0.001). This trend persisted throughout the 3-year follow-up period. Higher PAID-K scores were associated with younger age, female gender, longer duration of diabetes, and higher carbohydrate intake (all p < 0.05). There was a significant association between high distress and diabetic neuropathy (adjusted odds ratio, 1.63; p = 0.002), but no significant association was found with other complications, including retinopathy, albuminuria, and carotid artery plaque. In conclusion, high diabetes distress was associated with uncontrolled hyperglycemia and higher odds of having diabetic neuropathy.

26 January 2022 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
DSDa Hea Seo
Da Hea Seo
YSYoung Ju Suh
Young Ju Suh
YCYongin Cho
Yongin Cho
SASeong Hee Ahn
Seong Hee Ahn
SSSeongha Seo
Seongha Seo
SKSo Hun Kim
So Hun Kim
Background: Nonalcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). However, the causal relationship between NAFLD and CKD is uncertain, particularly in patients with type 2 diabetes mellitus (T2DM). We aimed to investigate the association between the presence and severity of NAFLD and incident CKD in patients with T2DM.Methods: In this longitudinal cohort study of patients with T2DM, 3,188 patients with preserved renal function were followed up for the occurrence of incident CKD. NAFLD was defined as the presence of hepatic steatosis on ultrasonography, without any other causes of chronic liver disease. Advanced liver fibrosis of NAFLD was defined as a fibrosis-4 index ≥2.67. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2.Results: At baseline, 1,729 (54.2%) patients had NAFLD, of whom 94 (5.4%) had advanced liver fibrosis. During the follow-up of 8.3±3.6 years, 472 (14.8%) patients developed incident CKD: 220 (15.1%) in the non-NAFLD group, 231 (14.1%) in the NAFLD without advanced fibrosis group and 28 (31.1%) in the NAFLD with advanced fibrosis group. There was no increased risk of incident CKD in the NAFLD group compared to the non-NAFLD group (P=0.435). However, among patients with NAFLD, advanced liver fibrosis was associated with an increased risk of CKD (adjusted hazard ratio, 1.75; 95% confidence interval, 1.15 to 2.66; P=0.009).Conclusion: Advanced liver fibrosis in patients with NAFLD is independently associated with an increased risk of incident CKD in patients with T2DM.


1 January 2019 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
DSDa Hea Seo
Da Hea Seo
SKShinae Kang
Shinae Kang
YLYong-ho Lee
Yong-ho Lee
JHJung Yoon Ha
Jung Yoon Ha
JPJong Suk Park
Jong Suk Park
BCBong-Soo Cha
Bong-Soo Cha
This study investigated the overall status of diabetes control and screening for diabetic microvascular complications in patients with type 2 diabetes mellitus attending primary care clinics in Korea. In this cross-sectional observational study, 191 primary care clinics were randomly selected across Korea from 2015 to 2016. In total, 3,227 subjects were enrolled in the study. The patients followed at the primary care clinics were relatively young, with a mean age of 61.4±11.7 years, and had a relatively short duration of diabetes (mean duration, 7.6±6.5 years). Approximately 14% of subjects had diabetic microvascular complications. However, the patients treated at the primary care clinics had suboptimal control of hemoglobin A1c levels, blood pressure, and serum lipid levels, along with a metabolic target achievement rate of 5.9% according to the Korean Diabetes Association guidelines. The screening rates for diabetic nephropathy, retinopathy, and neuropathy within the past 12 months were 28.4%, 23.3%, and 13.3%, respectively. The overall status of diabetes management, including the frequency of screening for microvascular complications, was suboptimal in the primary care clinics. More efforts should be made and more resources need to be allocated for primary care physicians to promote adequate healthcare delivery, which would result in stricter diabetes control and improved management of diabetic complications.

1 January 2019 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
DSDa Hea Seo
Da Hea Seo
SKSo Hun Kim
So Hun Kim
JSJoon Ho Song
Joon Ho Song
SHSeongbin Hong
Seongbin Hong
YSYoung Ju Suh
Young Ju Suh
OGon Behalf of the KNDP Study Group
on Behalf of the KNDP Study Group
Seo DH, et al. Diabetes Metab J. 2019 Jan;43:e18. https://doi.org/10.4093/dmj.2018.0186

31 December 2020 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
DSDa Hea Seo
Da Hea Seo
MNMoonsuk Nam
Moonsuk Nam
MJMihye Jung
Mihye Jung
YSYoung Ju Suh
Young Ju Suh
SASeong Hee Ahn
Seong Hee Ahn
SKSo Hun Kim
So Hun Kim
Seo DH, et al. Diabetes Metab J. 2020 Jan;44:e37. https://doi.org/10.4093/dmj.2019.0221